Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease
Phase 2
Completed
- Conditions
- GERD
- Interventions
- First Posted Date
- 2020-02-25
- Last Posted Date
- 2022-07-13
- Lead Sponsor
- Onconic Therapeutics Inc.
- Target Recruit Count
- 188
- Registration Number
- NCT04282954
- Locations
- 🇰🇷
Severance Hospital and 19 hospitals, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath